Sermorelin Side Effects: What Studies and Users Report
What FDA labels and clinical studies report for Sermorelin, how strong that evidence is, and what is still unknown.
Side effects reported in studies
Side effects reported in published studies, strongest design first. Frequencies are quoted as the source gives them; animal results are labelled.
| Side effect | How common | Study type | Source |
|---|---|---|---|
| Safety labs“GHRH treatment did not affect fasting glucose, urinary C-peptide, blood pressure, or chemistry and hematology profiles.” | Frequency not stated | Human RCTn = 10 | The Journal of clinical endocrinology and metabolism 1992, PMID 1379256 |
| Adverse effects“No significant adverse effects were observed.” | Frequency not stated | Human uncontrolled trialn = 11 | Metabolism: clinical and experimental 1997, PMID 9005976 |
| Safety“No adverse changes in general biochemical or hormonal analyses were noted. No change in fasting glucose concentration or excessive generation of insulin-like growth factor I occurred, and overall GHRH was well tolerated.” | Frequency not stated | Human uncontrolled trialn = 110 | The Journal of clinical endocrinology and metabolism 1996, PMID 8772599 |
| Flushing and injection-site pain | most commonly reported | Review | BioDrugs 1999, PMID 18031173 |
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How Sermorelin interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
Common questions
What are the side effects of Sermorelin?
Studies we summarise reported safety labs, adverse effects, safety. The table on this page gives how often each happened and links each source.
Is Sermorelin safe?
Its safety has not been established by an FDA review. Sermorelin is not FDA approved for any use. Research-chemical products are not checked for purity or dose.
Is Sermorelin banned in sport?
Yes. Prohibited by WADA (S2.2.4). Tested athletes should not use it.
More on Sermorelin
Sources
- 1Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.The Journal of clinical endocrinology and metabolism · 1992PMID 1379256Accessed 2 Oct 2026
- 2Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.Metabolism: clinical and experimental · 1997PMID 9005976Accessed 2 Oct 2026
- 3Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.The Journal of clinical endocrinology and metabolism · 1996PMID 8772599Accessed 2 Oct 2026
- 4Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 1999PMID 18031173Accessed 2 Oct 2026
Found an error? Report a correction.